Cargando…
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions
Oncolytic virotherapy for cancer is an innovative therapeutic option where the ability of a virus to promote cell lysis is harnessed and reprogrammed to selectively destroy cancer cells. Such treatment modalities exhibited antitumor activity in preclinical and clinical settings and appear to be well...
Autores principales: | Kim, Janice, Hall, Robert R., Lesniak, Maciej S., Ahmed, Atique U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690850/ https://www.ncbi.nlm.nih.gov/pubmed/26633462 http://dx.doi.org/10.3390/v7122921 |
Ejemplares similares
-
Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice
por: Auffinger, Brenda, et al.
Publicado: (2013) -
Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: Targeted delivery of the therapeutic payload in an orthotopic brain tumor model
por: Thaci, Bart, et al.
Publicado: (2012) -
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
por: Dey, Mahua, et al.
Publicado: (2016) -
Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
por: Mahasa, Khaphetsi Joseph, et al.
Publicado: (2020) -
Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy
por: Wang, Xianyao, et al.
Publicado: (2021)